Author
Listed:
- Michal S. Barski
(Section of Virology, Norfolk Place
Polish Academy of Sciences)
- Teresa Vanzo
(Section of Virology, Norfolk Place
University of Trento)
- Xue Zhi Zhao
(National Cancer Institute)
- Steven J. Smith
(Centre for Cancer Research, National Cancer Institute)
- Allison Ballandras-Colas
(The Francis Crick Institute)
- Nora B. Cronin
(The Francis Crick Institute)
- Valerie E. Pye
(The Francis Crick Institute)
- Stephen H. Hughes
(Centre for Cancer Research, National Cancer Institute)
- Terrence R. Burke
(National Cancer Institute)
- Peter Cherepanov
(Section of Virology, Norfolk Place
The Francis Crick Institute)
- Goedele N. Maertens
(Section of Virology, Norfolk Place)
Abstract
Between 10 and 20 million people worldwide are infected with the human T-cell lymphotropic virus type 1 (HTLV-1). Despite causing life-threatening pathologies there is no therapeutic regimen for this deltaretrovirus. Here, we screened a library of integrase strand transfer inhibitor (INSTI) candidates built around several chemical scaffolds to determine their effectiveness in limiting HTLV-1 infection. Naphthyridines with substituents in position 6 emerged as the most potent compounds against HTLV-1, with XZ450 having highest efficacy in vitro. Using single-particle cryo-electron microscopy we visualised XZ450 as well as the clinical HIV-1 INSTIs raltegravir and bictegravir bound to the active site of the deltaretroviral intasome. The structures reveal subtle differences in the coordination environment of the Mg2+ ion pair involved in the interaction with the INSTIs. Our results elucidate the binding of INSTIs to the HTLV-1 intasome and support their use for pre-exposure prophylaxis and possibly future treatment of HTLV-1 infection.
Suggested Citation
Michal S. Barski & Teresa Vanzo & Xue Zhi Zhao & Steven J. Smith & Allison Ballandras-Colas & Nora B. Cronin & Valerie E. Pye & Stephen H. Hughes & Terrence R. Burke & Peter Cherepanov & Goedele N. Ma, 2021.
"Structural basis for the inhibition of HTLV-1 integration inferred from cryo-EM deltaretroviral intasome structures,"
Nature Communications, Nature, vol. 12(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25284-1
DOI: 10.1038/s41467-021-25284-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25284-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.